AG
AEGR

Artal Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

Artal Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,000,000
Closed -$2.97M – 108
2016
Q3 		$2.97M Hold
1,000,000
– – 0.06% 76
2016
Q2 		$1.49M Buy
+1,000,000
New +$2.29M 0.03% 65

Artal Group's AEGR Position: Q4 2016 in Review

Artal Group sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 1,000,000 shares — an estimated $2.97M sold.

Artal Group first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $2.97M in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Artal Group reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Artal Group sold 1,000,000 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $2.97M.
  • Artal Group first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Artal Group's Aegerion Pharmaceuticals position peaked at $2.97M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Artal Group's 13F filing for Q4 2016, filed 14 Feb 2017.